Clinical trial
Patient-derived Organoids of Lung Cancer to Test Drug Response
NCT03979170 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient-derived Organoids of Lung Cancer to Test Drug Response
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2019
- Completion date
- December 30, 2029
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, organoid